Is fidaxomicin the drug of choice for treating clostridium difficile - Associated diarrhea in patients with cancer?

Myke R. Green, Utkarsh H. Acharya, Andrew M Yeager

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)4376-4378
Number of pages3
JournalJournal of Clinical Oncology
Volume31
Issue number34
DOIs
StatePublished - Dec 1 2013

Fingerprint

Pseudomembranous Enterocolitis
Clostridium difficile
Aminoglycosides
Vancomycin
Diarrhea
Anti-Bacterial Agents
Pharmaceutical Preparations
Neoplasms
lipiarmycin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Is fidaxomicin the drug of choice for treating clostridium difficile - Associated diarrhea in patients with cancer? / Green, Myke R.; Acharya, Utkarsh H.; Yeager, Andrew M.

In: Journal of Clinical Oncology, Vol. 31, No. 34, 01.12.2013, p. 4376-4378.

Research output: Contribution to journalArticle

@article{1d21a517f80944f7a82340e0fd1abc1c,
title = "Is fidaxomicin the drug of choice for treating clostridium difficile - Associated diarrhea in patients with cancer?",
author = "Green, {Myke R.} and Acharya, {Utkarsh H.} and Yeager, {Andrew M}",
year = "2013",
month = "12",
day = "1",
doi = "10.1200/JCO.2013.52.8513",
language = "English (US)",
volume = "31",
pages = "4376--4378",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "34",

}

TY - JOUR

T1 - Is fidaxomicin the drug of choice for treating clostridium difficile - Associated diarrhea in patients with cancer?

AU - Green, Myke R.

AU - Acharya, Utkarsh H.

AU - Yeager, Andrew M

PY - 2013/12/1

Y1 - 2013/12/1

UR - http://www.scopus.com/inward/record.url?scp=84892863457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892863457&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.52.8513

DO - 10.1200/JCO.2013.52.8513

M3 - Article

VL - 31

SP - 4376

EP - 4378

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 34

ER -